Moses Lake Pharmacy Recalls Medroxyprogesterone Acetate Syringes Due to Sterility Concerns
Moses Lake Professional Pharmacy is recalling 11 syringes of Medroxyprogesterone Acetate because the FDA determined there is a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this recall as Class II. According to the rubric, an FDA Class II recall involving a sterile injectable drug where sterility is not assured is categorized as Severe (Score 4) due to the potential for significant injury or infection.
Plain-English summary
JD & SN Inc., dba Moses Lake Professional Pharmacy, is recalling 11 syringes of Medroxyprogesterone Acetate, 150mg/mL, 10mL. The recall was initiated because the U.S. Food and Drug Administration determined there is a lack of assurance of sterility for the product.
The affected product is a prescription-only injectable solution. The recall covers specific lots identified by the codes t03182015@4 and t07062015@5. The distribution pattern for these products is listed as nationwide.
Consumers who have this product should stop using it and contact their healthcare provider or the pharmacy for further instructions. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- MEDROXYPROGESTERONE ACETATE, injectable Solution,150MG/ML, 10mL syringe, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
- Category
- Drug — Injectable Sterile
- Affected units
- 11
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- t03182015@4 and t07062015@5
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 101 recalled by JD & SN Inc., dba Moses Lake Professional Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 101 products in this recall →Related recalls
Same manufacturer · JD & SN Inc., dba Moses Lake Professional Pharmacy
See all →- SevereFDA Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Sodium Tetradecyl Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Six Trimix Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Compounded Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Compounded Progesterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- HighMedroxyprogesterone Acetate Injectable Suspension Recalled for Sterility Concerns
FDA (Drugs) · 2022-06-22
- SevereGreen Valley Drugs Recalls Medroxyprogesterone Acetate Injection for Sterility Concerns
FDA (Drugs) · 2013-05-22
- HighInjectable hormone medication recalled for sterility assurance failure
FDA (Drugs) · 2022-11-09
- SevereWestern Drug Recalls Medroxyprogesterone Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereMedroxyprogesterone Injection Recalled Due to Sterility Concerns
FDA (Drugs) · 2013-07-10
- HighMedroxyprogesterone Acetate Injectable Suspension Recalled for Sterility Assurance Failure
FDA (Drugs) · 2022-06-22